Skip to main content

Edwards Lifesciences Corp balance sheet

  • EW · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$107.15+1.28%Close 13 Nov 2026 · Market value $61.51B

At the end of fiscal 2025 (the year to 31 Dec 2025), Edwards Lifesciences Corp reported total assets of $13.70B, $2.94B in cash and equivalents, $705.4M of total debt; shareholders' equity was $10.34B.

From Edwards Lifesciences Corp's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025.

Annual

Edwards Lifesciences Corp balance sheet, annual
USDFY 2008FY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Cash and equivalents$218.7M$334.1M$396.1M$171.2M$310.9M$420.4M$653.8M$718.4M$930.1M$818.3M$714.1M$1.18B$1.18B$862.8M$769.0M$1.13B$3.05B$2.94B
Short-term investments———$279.3M$210.5M$516.5M$785.0M$506.3M$341.0M$519.2M$242.4M$337.8M$219.4M$604.0M$446.3M$500.5M$930.7M$1.29B
Cash and short-term investments$218.7M$334.1M$396.1M$450.5M$521.4M$936.9M$1.44B$1.22B$1.27B$1.34B$956.5M$1.52B$1.40B$1.47B$1.22B$1.63B$3.98B$4.23B
Accounts receivable—$249.4M$277.3M$283.8M$321.1M$302.5M$288.0M$315.4M$365.5M$438.7M$456.9M$543.6M$514.6M$582.2M$643.0M$771.5M$609.1M$659.6M
Inventory—$165.9M$203.6M$261.3M$281.0M$308.9M$296.8M$339.9M$396.6M$554.9M$607.0M$640.9M$802.3M$726.7M$875.5M$903.5M$1.09B$1.13B
Current assets—$889.2M$1.03B$1.17B$1.29B$1.73B$2.23B$2.05B$2.24B$2.55B$2.29B$2.98B$3.09B$3.18B$3.10B$4.04B$6.29B$6.74B
Property, plant and equipment—$252.0M$269.8M$304.3M$373.3M$421.6M$442.9M$482.5M$580.0M$679.7M$867.5M$1.06B$1.40B$1.55B$1.63B$1.59B$1.69B$1.81B
Goodwill$315.7M$315.2M$315.2M$349.8M$384.7M$385.4M$376.0M$628.3M$626.1M$1.13B$1.11B$1.17B$1.17B$1.17B$1.16B$1.15B$1.78B$1.77B
Acquired intangibles—$86.70M$67.10M$66.90M$67.00M$33.50M$23.40M$205.4M$204.8M$468.0M$343.2M$336.5M$331.4M$323.6M$285.2M$399.4M$1.18B$1.13B
Long-term investments—$22.30M$25.00M$21.80M$21.10M$21.90M$240.9M$379.9M$532.1M$567.0M$506.3M$585.5M$801.6M$1.83B$1.24B$583.9M$307.9M$278.6M
Total assets—$1.62B$1.77B$1.98B$2.22B$2.71B$3.52B$4.06B$4.51B$5.67B$5.32B$6.49B$7.24B$8.50B$8.29B$9.36B$13.06B$13.70B
Accounts payable—$51.10M$47.60M$85.00M$74.70M$48.40M$58.20M$63.90M$97.10M$116.6M$134.0M$180.4M$196.5M$204.5M$201.9M$186.6M$197.4M$227.5M
Long-term debt · current portion————————$0.00$598.0M$0.00———————
Current liabilities—$290.5M$337.8M$335.2M$347.4M$345.6M$426.1M$476.2M$532.5M$1.42B$876.6M$902.4M$893.9M$1.03B$1.02B$1.20B$1.51B$1.81B
Long-term debt · non-current—$90.30M——$189.3M$593.1M$598.1M$596.9M$822.3M$438.4M$593.8M$594.4M$595.0M$595.7M$596.3M$597.0M$597.7M$598.3M
Operating lease liability———————————$84.40M$99.90M$94.60M$95.00M$88.10M$102.3M$107.1M
Total liabilities—$457.6M$459.0M$642.6M$742.2M$1.17B$1.33B$1.55B$1.89B$2.71B$2.18B$2.34B$2.66B$2.67B$2.49B$2.64B$2.99B$3.36B
Retained earnings—$906.0M$1.12B$1.36B$1.65B$2.03B$2.84B$3.34B$3.91B$1.96B$2.69B$3.74B$4.57B$6.07B$7.59B$8.99B$13.17B$14.24B
Minority interest$0.00—————————————$0.00$69.40M$64.50M$0.00
Shareholders' equity$878.8M$1.16B$1.31B$1.34B$1.48B$1.54B$2.19B$2.50B$2.62B$2.96B$3.14B$4.15B$4.57B$5.84B$5.81B$6.65B$10.00B$10.34B
Total liabilities and equity—$1.62B$1.77B$1.98B$2.22B$2.71B$3.52B$4.06B$4.51B$5.67B$5.32B$6.49B$7.24B$8.50B$8.29B$9.36B$13.06B$13.70B
Total debt—$90.30M——$189.3M$600.0M$598.1M$596.9M$822.3M$1.04B$593.8M$678.8M$694.9M$690.3M$691.3M$685.1M$700.0M$705.4M
Net debt—−$243.8M——−$332.1M−$336.9M−$840.7M−$627.8M−$448.8M−$301.1M−$362.7M−$838.1M−$707.7M−$776.5M−$524.0M−$947.7M−$3.28B−$3.52B
Net working capital—$264.6M$298.7M$662.1M$633.6M$959.8M$1.15B$853.3M$777.4M$310.9M$696.2M$902.5M$1.01B$1.29B$1.30B$1.71B$1.74B$1.99B
Shares outstanding · period end—341M690M685M686M656M323M646M635M629M623M209M624M624M608M601M589M581M

Quarterly

Edwards Lifesciences Corp balance sheet, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Cash and equivalents$1.13B$1.22B$1.64B$3.68B$3.05B$3.14B$3.27B$2.69B$2.94B$2.45B$2.91B$3.11B
Short-term investments$500.5M$473.0M$345.3M$769.7M$930.7M$757.9M$789.4M$1.16B$1.29B$1.23B$1.35B$1.53B
Cash and short-term investments$1.63B$1.70B$1.99B$4.45B$3.98B$3.90B$4.06B$3.84B$4.23B$3.67B$4.25B$4.64B
Accounts receivable$771.5M$817.6M$778.3M$716.0M$609.1M$669.2M$697.0M$693.3M$659.6M$775.7M$770.4M$784.9M
Inventory$903.5M$1.21B$1.02B$1.10B$1.09B$1.11B$1.14B$1.14B$1.13B$1.12B$1.13B$1.16B
Current assets$4.04B$4.17B$4.52B$6.73B$6.29B$6.21B$6.58B$6.36B$6.74B$6.23B$6.82B$7.25B
Property, plant and equipment$1.59B$1.77B$1.64B$1.68B$1.69B$1.70B$1.73B$1.74B$1.81B$1.82B$1.84B$1.86B
Goodwill$1.15B$1.25B$1.15B$1.61B$1.78B$1.78B$1.78B$1.77B$1.77B$1.82B$1.95B$1.95B
Acquired intangibles$399.4M$446.8M$417.1M$956.1M$1.18B$1.17B$1.17B$1.13B$1.13B$1.23B$1.38B$1.16B
Long-term investments$583.9M$455.6M$353.3M$319.6M$307.9M$277.9M$298.5M$274.7M$278.6M$285.6M$244.1M$262.6M
Total assets$9.36B$9.74B$10.10B$12.97B$13.06B$13.02B$13.49B$13.27B$13.70B$13.32B$13.87B$14.14B
Accounts payable$186.6M$212.3M$185.9M$172.8M$197.4M$172.4M$162.1M$165.0M$227.5M$181.1M$210.5M$199.7M
Current liabilities$1.20B$1.11B$1.22B$1.94B$1.51B$1.39B$1.40B$1.59B$1.81B$1.41B$1.51B$1.58B
Long-term debt · non-current$597.0M$597.2M$597.3M$597.5M$597.7M$597.8M$598.0M$598.2M$598.3M$598.5M$598.7M$598.8M
Operating lease liability$88.10M———$102.3M———$107.1M———
Total liabilities$2.64B$2.55B$2.59B$3.36B$2.99B$2.83B$2.88B$3.07B$3.36B$2.99B$3.14B$3.18B
Retained earnings$8.99B$9.34B$9.71B$12.78B$13.17B$13.53B$13.86B$14.15B$14.24B$14.62B$14.86B$15.17B
Minority interest$69.40M$68.50M$67.20M$65.80M$64.50M$62.90M$61.20M$0.00$0.00—$106.9M$100.4M
Shareholders' equity$6.65B$7.12B$7.44B$9.55B$10.00B$10.13B$10.55B$10.21B$10.34B$10.33B$10.62B$10.86B
Total liabilities and equity$9.36B$9.74B$10.10B$12.97B$13.06B$13.02B$13.49B$13.27B$13.70B$13.32B$13.87B$14.14B
Total debt$685.1M$699.2M$693.0M$706.7M$700.0M$699.4M$702.6M$700.3M$705.4M$702.9M$704.4M$704.5M
Net debt−$947.7M−$998.4M−$1.30B−$3.74B−$3.28B−$3.20B−$3.36B−$3.14B−$3.52B−$2.97B−$3.55B−$3.94B
Net working capital$1.71B$1.84B$1.65B$1.11B$1.74B$1.68B$1.90B$2.09B$1.99B$2.37B$2.40B$2.56B
Shares outstanding · period end601M602M602M590M589M586M588M581M581M577M577M576M

The main figures as JSON and plain text. See data and methodology.

EW in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.